Honokiol, a natural biphenolic compound, exerts anticancer effects through a variety of mechanisms on multiple types of
cancer with relatively low toxicity.
Adenosine 5'‑phosphate‑activated
protein kinase (AMPK), an essential regulator of cellular homeostasis, may control
cancer progression. The present study aimed to investigate whether the anticancer activities of
honokiol in
ovarian cancer cells were mediated through the activation of AMPK.
Honokiol decreased cell viability of 2
ovarian cancer cell lines, with an half‑maximal inhibitory concentration value of 48.71±11.31 µM for SKOV3 cells and 46.42±5.37 µM for Caov‑3 cells.
Honokiol induced apoptosis via activation of caspase‑3, caspase‑7 and caspase‑9, and cleavage of poly‑(
adenosine 5'‑diphosphate‑ribose) polymerase. Apoptosis induced by
honokiol was weakened by compound C, an AMPK inhibitor, suggesting that honokiol‑induced apoptosis was dependent on the AMPK/mechanistic target of
rapamycin signaling pathway. Additionally,
honokiol inhibited the migration and invasion of
ovarian cancer cells. The combined treatment of
honokiol with compound C reversed the activities of
honokiol in wound healing and
Matrigel invasion assays. These results indicated that
honokiol may have therapeutic potential in
ovarian cancer by targeting AMPK activation.